
    
      Sample Size: N= 60 completed subjects Male and female subjects 12 years or older diagnosed
      with mild to moderate inflammatory facial acne vulgaris.

      Subjects will be treated with once daily topical NAG or matching vehicle and will attend
      screening, randomization, 2,4,8 and 12 week visits. The following will be assessed:

        1. Lesion counts with photography

        2. Investigator Global Assessment

        3. Acne Quality of Life Questionnaire

        4. Treatment Area Assessment by Investigator

      Subjects will discontinue all baseline topical acne treatments with a 2 week washout and/or
      all systemic acne treatments with a 3 week washout. All subjects will be provided open label
      Cetaphil facial cleanser and double-blind NAG or vehicle product.
    
  